
PRINT THIS PAGE Institutional Investor Profile: Rupert Montagu, Co-Founder and General Partner, Montagu Newhall20/09/2004. Source: AltAssets. 
Montagu on the value of identifying quality emerging management teams in their early years, on the importance of gaining vintage year diversification, on a shift in the balance of power between entrepreneurs and VCs and on the crack that is just beginning to appear in the IPO window. Montagu Newhall is a venture capital fund of funds with a particular focus
on early-stage investments. The firm was founded early in 2001 and its four investment
professionals are based in both the UK and US. Montagu Newhall currently has approximately
$106m under management for both fund and co-investments in the US, Europe and
Israel. Montagu co-founded the firm with Ashton Newhall and was previously at
Altius Associates.
How did Montagu Newhall come about?
‘The firm was founded by Ashton Newhall and myself at the very beginning
of 2001. I had been working at Altius Associates in London and Ashton has been
working at T. Rowe Price in the US. We already had a strong professional relationship
because, at the time, these two organisations were planning a joint venture
to create a private equity fund of funds product. So, when the project was pulled
for broader strategic reasons, Ashton and I decided to leave our respective
jobs and form Montagu Newhall.
‘We had actually known each other, through family connections, for many
years prior to this. Ashton’s father founded New Enterprise Associates
back in the 1970s, at about the same time my father was founding Abingworth.
Abingworth and NEA have co-invested successfully over many years and I think
this link gave us the encouragement that we required to launch our own venture
capital fund of funds.
Why did you choose to focus purely on venture capital?
We decided to focus on venture capital as opposed to later-stage private equity
because that is one area where we have particularly strong relationships. As
a result of our extensive network we felt that we would be able to create a
highly differentiated product in this space. We were also aware that these relationships
could be invaluable in helping us to gain access to the very best venture capital
funds being raised.’
What about your particular focus on early-stage venture capital?
‘We decided to focus our investment strategy predominantly on early-stage
funds because we feel that this is where the most rewarding opportunities are
often to be found. If you look at the returns that have been generated historically
across the venture capital industry, you will find that early-stage investments
have outperformed later-stage investments to a very great extent.
‘However, we do occasionally also make investments in funds that have
a later-stage venture capital profile. Although this type of investment forms
a relatively small piece of our overall portfolio, it is important to recognise
that there are some extremely talented later-stage managers that have performed
at least as well as the very best early-stage funds that we see. These funds
also have the added advantage of generating liquidity at an earlier stage.’
Beyond your emphasis on early-stage funds, what type of investments
do you look for?
‘Geographically speaking, we focus predominantly on the US. In fact,
just over 90 per cent of our first fund has now been deployed there, while the
remainder is invested in Europe and Israel. I expect our geographic allocation
to continue in a similar vein going forward.
‘Within the US, we aim to gain a broad exposure across each of the main
markets. We inevitably invest a great deal on the West Coast, and also on the
East Coast, particularly in the Boston and MidAtlantic areas. In addition, we
try to identify up and coming centres of excellence that we feel will generate
good companies and good returns in the future. One example of this is a recent
investment that we made in North Carolina’s Research Triangle.
‘In terms of sector, what we are trying to do is to provide the most
diversified product that we possibly can for our investors. We focus on the
three core elements of venture capital investing; information technology, communications
and healthcare and life sciences, and we aim to invest fairly evenly across
this spectrum.’
Are there any areas or industries that you feel are particularly exciting
at the moment?
‘We have always had a particular interest in the healthcare and life
sciences sector, particularly in speciality pharmaceuticals and medical devices.
We actually ended up deploying slightly more than a third of our first fund
in this area. Not only do we have very good relationships with a number of extremely
talented managers in this field, but we also believe that the fundamental building
blocks of success are in place to take this industry from strength to strength.
An aging population, combined with significant scientific development, makes
for a very interesting investment proposition indeed.
‘We have always tended to be a little more cautious in the communications
area. Companies in this sector have experienced some very difficult times following
the bursting of the internet bubble and, as a result, we have approached this
market with a certain degree of caution in the first few years of our business.’
What are your views on the venture market in general?
‘I think that things are definitely looking more positive for the venture
industry as a whole. Although, with the bursting of the bubble, the quantity
of deal flow fell significantly, the average quality of deal flow has risen
quite dramatically.
‘But while there has at no stage been a shortage of deals to invest in,
the real risk in recent years has been an almost total lack of exit opportunities,
particularly through IPOs. This is now starting to change. While the IPO window
is certainly not wide open, there is a crack beginning to appear. This has been
evident in the number of companies that have managed to go public over the last
few months and is a very welcome relief for a lot of venture capital firms that
have been anxious to exit their existing portfolio companies in order to move
on and make new investments.’
What about European venture?
‘As a European myself I get incredibly frustrated because it is clear
to me that the underlying technology in Europe is at least as impressive as
anything you will find in the US. But unfortunately, the less mature European
venture capital industry has, as yet, failed to deliver the types of returns
that investors have come to expect from the US market.
‘If you look at a US venture portfolio you generally see a number of
investments that have generated two or three times the capital invested. You
then also see a small handful of outstanding investments that have generated
ten, 20 or even 30 times the initial investment. It is these home runs that
really give the overall portfolio a significant out performance. Unfortunately,
in Europe, home runs are few and far between and without them it will be incredibly
hard for European venture capital to compete with the US.
‘Having said that we have deployed approximately ten per cent of our
first fund in Europe and Israel and that is because we want to take advantage
of the technology that is being created there. There are definitely some funds
that really are worth investing in, and that we think will produce very comparable
returns to the top tier US funds.’
How many investments do you typically make in a year?
‘We typically aim to make six or seven fund commitments in a year, with
the objective of having around 20 to 25 underlying fund commitments in a fund
portfolio. We are more opportunistic with our co-investment strategy and we
generally go at the speed at which good opportunities present themselves. We
have ended up on average completing between three and five co-investment deals
per year and would expect to continue at a similar rate going forward.’
What size of investment do you typically make?
‘Our bite size can vary considerably. If we are making a commitment to
a long established firm, we will typically commit around $5m or $6m. We also
reserve a portion of our capital for emerging managers and we would generally
invest between $1m and $4m in a newer fund. Our co-investments usually fall
in the $500,000 to $2m range.’
Why have you chosen to reserve capital for emerging managers?
‘There are a number of emerging managers that we believe will generate
returns that are at least as good as the top tier long established managers.
We decided to reserve some capital for these types of managers because we believe
they represent the future of the industry and we want to reserve our seat at
the table.
‘But it is important to point out that for us, an emerging manager is
rarely a team that is raising its first or even second fund, although we may
look at such opportunities under special circumstances. Our emerging managers
are typically teams that are raising their third, fourth or even sometimes their
fifth fund. You have to consider this in the context of the US venture market
where a lot of the long established managers are now raising their tenth or
perhaps eleventh fund.’
How do you find out about good investment opportunities?
‘We know a lot of the long established managers extremely well already
and we make sure that we stay as close to them as possible in order to ensure
that we gain access to their new funds. If you read about a top tier firm that
is looking to raise a fund, the chances are that by the time you have dialled
their number it will be too late. It is essential to be proactive.’
What do you look for in a good fund manager?
‘One of our key concerns when assessing an investment proposition is
whether or not a firm has adequately taken care of the succession issue. We
have turned down a number of funds for that very reason. We need to feel confident
about who will be running the firm going forward.
‘There are a number of other attributes that we look for in a good manager.
We like to see a team with broad venture capital and operational experience,
as well as healthy team dynamics. We also like to see a consistent track record
that has not been sustained by one or two big hits, but that has a convincing
breadth and depth across all previous funds.
‘In addition, we look for a firm with a consistent investment strategy.
We have seen a lot of venture firms that have swung wildly from one investment
strategy to the next and we have tended to avoid those and have focused instead
on teams that have maintained the same strategy over multiple funds. And finally,
we look to find managers that have generated a lot of respect in the LP community,
GP community, and most importantly in the entrepreneurial community.’
How do you go about conducting your due diligence?
‘In any one year there are hundreds of venture capital funds raised and
what we do initially is to screen those funds to see whether they will fit into
our portfolio. In order to fit into our portfolio a fund should be targeting
at least $100m, have a pure venture capital profile, as well as being focused
on the right sectors and the right geographies.
‘We then complete a detailed questionnaire to ensure that all the ‘i’s
are dotted and all the ‘t’s are crossed. We spend a great deal of
time talking to other LPs, other venture capital firms and also to portfolio
companies, in order to gain a wide range of perspectives on whether that fund
is likely to continue to generate good returns in the future.
‘We also hold extensive talks with our advisory board members, a number
of whom are founding partners of leading venture capital firms in both US and
Europe. This is, of course, incredibly valuable when it comes to assessing investment
opportunities.’
What advice would you give a new investor in private equity?
‘First and foremost, I would advise a new investor in private equity
to ensure that they achieve good vintage year diversification. Like wine, it
is rather hard to know at the beginning how a particular year is going to turn
out. It is therefore very important to continue to make commitments annually
to the asset class. If you do so, theoretically speaking at least, you will
be able to use your distributions from the good years to meet drawdowns and
ultimately, your investment strategy will become self-perpetuating.
‘It is also essential to make commitments to funds that are being raised
by experienced and proven teams. In the late 1990s and early 2000, a lot of
firms were able to raise venture capital funds that perhaps should not have
been able to do so. The consequences of those years have provided investors
with a sharp reminder of the importance of investing with the best.
‘The only problem of course, is that it is extremely difficult to access
these top-performing funds. There are very few new investors that would be considered
by the most established firms. In addition, most venture capital firms are raising
much smaller funds than was previously the case, which is further exacerbating
the problem. As a result, I would say that the majority of new investors would
be well advised to use a fund of funds for diversification, expertise and access.
‘Ultimately, if you cannot gain access to the top performing funds, either
directly or through a fund of funds, then I genuinely don’t think that
it is worth getting into the asset class at all.’
How do you expect the market to evolve going forward?
‘During the bubble period entrepreneurs were very much in the driving
seat. But immediately after the bubble burst roles were reversed and venture
capitalists were in control and dictating the terms under which deals were done.
I think we are now gravitating toward a situation where there will be a much
better balance between the venture capital firms and start-up companies in structuring
deals. And I think this will be absolutely critical to producing good returns
long term.’
Copyright © 2004 AltAssets

|